INTRODUCTION: Providing smokers with biologically based evidence of smoking-related disease risk or physical impairment may be an effective way to motivate cessation. METHODS: Smokers were recruited for a free health risk assessment and randomized to receive personally tailored feedback based on their lung functioning, carbon monoxide (CO) exposure, and smoking-related health conditions or generic information about the risks of smoking and personalized counseling based on their diet, body mass index, and physical activity. All (n = 536) were advised to quit smoking and offered access to a free telephone cessation program. Participants were surveyed immediately after intervention and 1 month later to assess the impact on various indices of motivation to quit. RESULTS: Immediately posttreatment, experimental participants rated themselves as more likely to try to quit (p = .02) and reported a greater mean increase in their motivation to quit than controls (p = .04). At 1-month follow-up, however, we found no significant group differences on any motivational indices. In post-hoc analyses comparing smokers in the experimental group with and without lung impairment, persons with impaired lung functioning had a greater change from baseline in posttreatment motivation to quit (adjusted p = .05) and perceived risk of developing a smoking-related disease (p = .03) compared with persons with no lung impairment, but we found no significant treatment effect on any motivational indices at 1 month. DISCUSSION: The results suggest that the intervention had a small, temporary effect, but we found no clear evidence that the intervention increased motivation to quit smoking during the first month postintervention.
RCT Entities:
INTRODUCTION: Providing smokers with biologically based evidence of smoking-related disease risk or physical impairment may be an effective way to motivate cessation. METHODS: Smokers were recruited for a free health risk assessment and randomized to receive personally tailored feedback based on their lung functioning, carbon monoxide (CO) exposure, and smoking-related health conditions or generic information about the risks of smoking and personalized counseling based on their diet, body mass index, and physical activity. All (n = 536) were advised to quit smoking and offered access to a free telephone cessation program. Participants were surveyed immediately after intervention and 1 month later to assess the impact on various indices of motivation to quit. RESULTS: Immediately posttreatment, experimental participants rated themselves as more likely to try to quit (p = .02) and reported a greater mean increase in their motivation to quit than controls (p = .04). At 1-month follow-up, however, we found no significant group differences on any motivational indices. In post-hoc analyses comparing smokers in the experimental group with and without lung impairment, persons with impaired lung functioning had a greater change from baseline in posttreatment motivation to quit (adjusted p = .05) and perceived risk of developing a smoking-related disease (p = .03) compared with persons with no lung impairment, but we found no significant treatment effect on any motivational indices at 1 month. DISCUSSION: The results suggest that the intervention had a small, temporary effect, but we found no clear evidence that the intervention increased motivation to quit smoking during the first month postintervention.
Authors: Jeffery C Huffman; Ariana M Albanese; Kirsti A Campbell; Christopher M Celano; Rachel A Millstein; Carol A Mastromauro; Brian C Healy; Wei-Jean Chung; James L Januzzi; Linda M Collins; Elyse R Park Journal: Clin Trials Date: 2017-01-12 Impact factor: 2.486
Authors: Jennifer B McClure; Evette J Ludman; Louis Grothaus; Chester Pabiniak; Julie Richards Journal: Am J Prev Med Date: 2009-06-12 Impact factor: 5.043
Authors: Beverly B Green; Melissa L Anderson; Jerry Campbell; Andrea J Cook; Kelly Ehrlich; Sarah Evers; Yoshio N Hall; Clarissa Hsu; Dwayne Joseph; Predrag Klasnja; Karen L Margolis; Jennifer B McClure; Sean A Munson; Mathew J Thompson Journal: Contemp Clin Trials Date: 2019-01-08 Impact factor: 2.226
Authors: Jennifer D Marler; Craig A Fujii; Kristine S Wong; Joseph A Galanko; Daniel J Balbierz; David S Utley Journal: J Med Internet Res Date: 2020-10-02 Impact factor: 5.428